Otulana acquired 25,000 shares at a price of 38.8 US cents each, and now holds 50,000 shares.
Allergy Therapeutics closed up 0.7% to
Fri, 16th Mar 2018 17:30
Otulana acquired 25,000 shares at a price of 38.8 US cents each, and now holds 50,000 shares.
Allergy Therapeutics closed up 0.7% to
Friday 23 September | |
Biffa PLC | Trading Statement |
European Opportunities Trust PLC | Full Year Results |
Investec PLC | Trading Statement |
Smiths Group PLC | Full Year Results |
TheWorks.co.uk PLC | Full Year Results |
Monday 26 September | |
Atome Energy PLC | Half Year Results |
Chapel Down Group PLC | Half Year Results |
Concurrent Technologies PLC | Half Year Results |
CPPGroup PLC | Half Year Results |
Devolver Digital Inc | Half Year Results |
Dillistone Group PLC | Half Year Results |
Finsbury Food Group PLC | Full Year Results |
Frenkel Topping Group PLC | Half Year Results |
Immotion Group PLC | Half Year Results |
Likewise Group PLC | Half Year Results |
Microlise Group PLC | Half Year Results |
Next Fifteen Communications PLC | Half Year Results |
SpaceandPeople PLC | Half Year Results |
XLMedia PLC | Half Year Results |
Xpediator PLC | Half Year Results |
Tuesday 27 September | |
AG Barr PLC | Half Year Results |
Animalcare Group PLC | Half Year Results |
Billington Holdings PLC | Half Year Results |
Boku Inc | Half Year Results |
Card Factory PLC | Half Year Results |
Close Brothers Group PLC | Full Year Results |
Diaceutics PLC | Half Year Results |
Digitalbox PLC | Half Year Results |
ECSC Group PLC | Half Year Results |
Ergomed PLC | Half Year Results |
Ferguson PLC | Full Year Results |
FireAngel Safety Technology Group PLC | Half Year Results |
GENinCode PLC | Half Year Results |
Gresham House Energy Storage Fund PLC | Half Year Results |
K3 Capital Group PLC | Full Year Results |
Instem PLC | Half Year Results |
LifeSafe Holdings PLC | Half Year Results |
Medica Group PLC | Half Year Results |
Mission Group PLC | Half Year Results |
Mortgage Advice Bureau PLC | Half Year Results |
NAHL Group PLC | Half Year Results |
Origin Enterprises PLC | Full Year Results |
United Utilities Group PLC | Trading Statement |
Personal Group Holdings PLC | Half Year Results |
S&U PLC | Half Year Results |
Saga PLC | Half Year Results |
Serica Energy PLC | Half Year Results |
SSP Group PLC | Trading Statement |
tinyBuild Inc | Half Year Results |
Transense Technologies PLC | Full Year Results |
Yu Group PLC | Half Year Results |
Wednesday 28 September | |
1Spatial PLC | Half Year Results |
AVI Japan Opportunity Trust PLC | Half Year Results |
Avingtrans PLC | Full Year Results |
Blancco Technology Group PLC | Full Year Results |
boohoo Group PLC | Half Year Results |
Everyman Media Group PLC | Half Year Results |
Octopus Renewables Infrastructure Trust PLC | Half Year Results |
Shepherd Neame Ltd | Full Year Results |
Skillcast Group PLC | Half Year Results |
SolGold PLC | Full Year Results |
Thursday 29 September | |
Allergy Therapeutics PLC | Full Year Results |
Angle PLC | Half Year Results |
Avation PLC | Full Year Results |
Bango PLC | Half Year Results |
Cap-XX Ltd | Half Year Results |
Celadon Pharmaceuticals PLC | Half Year Results |
Crestchic PLC | Half Year Results |
Directa Plus PLC | Trading Statement |
McBride PLC | Full Year Results |
NAHL Group PLC | Half Year Results |
Next PLC | Half Year Results |
Novacyt SA | Half Year Results |
Physiomics PLC | Full Year Results |
Synairgen PLC | Half Year Results |
XLMedia PLC | Half Year Results |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
(Sharecast News) - Allergy Therapeutics updated the market on the financial year just ended on Friday, with the phase one 'Peanut PROTECT' trial, incorporating "ground-breaking" VLP technology, proceeding as planned, with site initiation visits imminent.
Read more(Alliance News) - Allergy Therapeutics PLC on Friday said it expects annual revenue to fall and, while sales are set to improve in the year ahead, it flagged higher costs.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read moreTRADING UPDATES: Longboat comes up empty; Intercede wins US contract
Read moreAllergy Therapeutics gets US FDA approval for peanut vaccine trial
Read moreTRADING UPDATES: Mobile Streams wins deal; East Imperial revenue jumps
Read moreUK shareholder meetings calendar - next 7 days
Read moreEXECUTIVE CHANGES: GSK adds scientific heft to board ahead of demerger
Read more(Sharecast News) - Biotechnology company Allergy Therapeutics announced positive top-line results from its exploratory field study 'G309' to evaluate the efficacy and safety of its short-course subcutaneous allergen-specific immunotherapy candidate 'Grass MATA MPL'.
Read moreAllergy Therapeutics shares jump on positive G309 trial results
Read moreEARNINGS UPDATES: Harbour Energy enters black; Fonix profit rises
Read moreIN BRIEF: Allergy Therapeutics cheers secondary endpoint results
Read more